Eplerenone and haemodialysis Patient Reports February 13, 2012
Eplerenone Side Effects Report #4592521-6
Eplerenone side effect was reported by a Health Professional from on Feb 14, 2005. Male patient, 47 years of age, weighting 243.0 lb, was diagnosed with cardiac failure congestive and was treated with Eplerenone. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac failure congestive, condition aggravated, haemodialysis, renal failure, supraventricular extrasystoles, weight increased. Eplerenone dosage: 25 MG (25 MG, ONCE DAILY), ORAL. During the same period patient was treated with ASPIRIN, ALLOPURINOL, CARVEDILOL, DIGOXIN, FENOFIBRATE, FUROSEMIDE, GABAPENTIN, INSULIN GLARGINE. Patient was hospitalized. Patient recovered.Eplerenone Side Effects Report #4596753-2
Eplerenone side effect was reported by a Health Professional from on Feb 21, 2005. Male patient, 47 years of age, weighting 243.0 lb, was diagnosed with cardiac failure congestive and was treated with Eplerenone. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac failure congestive, condition aggravated, ejection fraction decreased, haemodialysis, renal failure, supraventricular extrasystoles, weight increased. Eplerenone dosage: 25 MG (25 MG, ONCE DAILY), ORAL. During the same period patient was treated with ASPIRIN, ALLOPURINOL, CARVEDILOL, DIGOXIN, FENOFIBRATE, FUROSEMIDE, GABAPENTIN, INSULIN GLARGINE. Patient was hospitalized. Patient recovered.Eplerenone Side Effects Report #5004455-3
Eplerenone side effect was reported by a Health Professional from UNITED STATES on May 05, 2006. Male patient, 47 years of age, weighting 243.0 lb, was diagnosed with cardiac failure congestive and was treated with Eplerenone. After drug was administered, patient experienced the following side effects: arrhythmia supraventricular, atrial fibrillation
, blood albumin decreased, cardiac failure, condition aggravated, haemodialysis, protein total decreased, renal failure, ventricular arrhythmia. Eplerenone dosage: 25 MG (25 MG, ONCE DAILY), ORAL. During the same period patient was treated with ASPIRIN, ALLOPURINOL, CARVEDILOL, DIGOXIN, FENOFIBRATE, FUROSEMIDE, GABAPENTIN, INSULIN GLARGINE. Patient was hospitalized. Patient recovered.
Eplerenone and haemodialysis 